Covered recipient · General Payments record
MINAKSHI KHANNA
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2021–2024
$2,185.15
- Reported across 94 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,219.02 | 53 |
| Education | $95.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $139.52 | 6 |
| Incyte Corporation | $104.37 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $99.47 | 5 |
| Astellas Pharma US Inc | $95.00 | 1 |
| Alexion Pharmaceuticals, Inc. | $72.54 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $71.20 | 3 |
| Daiichi Sankyo Inc. | $69.77 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $61.67 | 3 |
| Deciphera Pharmaceuticals Inc. | $58.40 | 2 |
| Karyopharm Therapeutics Inc. | $51.23 | 2 |
| MENARINI SILICON BIOSYSTEMS, INC. | $49.59 | 3 |
| Stemline Therapeutics Inc. | $43.08 | 2 |
| Janssen Biotech, Inc. | $41.49 | 2 |
| PharmaEssentia USA Corporation | $34.72 | 2 |
| Genentech USA, Inc. | $33.88 | 1 |
| SOBI, INC | $33.59 | 1 |
| ABBVIE INC. | $32.37 | 1 |
| Blueprint Medicines Corporation | $30.14 | 1 |
| Acerta Pharma LLC | $28.41 | 1 |
| PFIZER INC. | $24.10 | 1 |
| Novocure Inc. | $23.94 | 1 |
| EISAI INC. | $23.25 | 1 |
| GlaxoSmithKline, LLC. | $20.63 | 1 |
| Mirati Therapeutics, Inc. | $19.50 | 1 |
| Celgene Corporation | $18.69 | 1 |
| Pharmacosmos Therapeutics Inc. | $17.04 | 1 |
| TAIHO ONCOLOGY, INC. | $16.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.